Saturday, April 26, 2014

Sydney Punching Way Below Its Weight in Academic Urology - A Need For Change

A Canadian urologist who is one of the most prominent academics in the field has often been quoted as stating that the two cities in the world that really punch below their weight in terms of urological publishing and international academic recognition are Sydney and Rome.  Sadly, I must agree with him. I can’t really speak for Rome but I can speak for Sydney.

I recently had a letter published in the Australian and New Zealand Journal of Surgery that quantifies the academic publishing output of Level D and E ‘titled’ academics in Melbourne and Sydney.  This refers to those who hold a position of Associate Professor or Professor respectively.  For some, the position may be honorary and given in return for doing a bit of unpaid teaching to medical students – these honorary titles are usually prefixed by the term Adjunct, Conjoint or Clinical.  Academics who are employed by the universities usually have their title followed by a descriptor such as ‘of surgery’ or ‘of urology.’  The requirements for a paid position are usually significantly greater than for honorary titles but some holders of honorary titles should not be underestimated for their academic contributions which at times may well exceed those in paid positions.

So back to my letter.  What I did was to search and manually identify any academic writings indexed on Pubmed/Medline that could be attributed to authors who carried a Level D or E title and made comparisons between Melbourne and Sydney.  The results were not surprising but also disturbing.  There were a similar number of those with level D or E academic titles in both cities but the overall publication output from Melbourne was more than double that of Sydney overall and per annum.  In Sydney, there was only one urologist who was publishing on average in excess of 5 pieces of academic writing per annum over the past 5 years compared to Melbourne where there were at least 3 with this level of output.

How do we explain this?  Both cities have public hospitals funded by similar models and both have excellent universities with well regarded medical courses.  Both cities have urology departments that are equally poorly funded and poorly supported by the public hospital system and universities.

I do have some thoughts as to why this is the case and of course many will beg to differ.  Some may unkindly suggest that Sydney urologists are so consumed by private practice and making money and to the extent that any academic pursuit is well down the list for matters of importance.  Whilst there might be some truth in this, it is clearly not as simple as this.

Whilst the funding models for public hospitals in Sydney and Melbourne are globally similar, there are some differences in how things have become structured over the years.  As a result of funding cuts to support public outpatient departments in NSW hospitals, the vast majority of patients seeking urological care must see a urologist in their private rooms before being referred to a public hospital for treatment.  This drives work to the private rooms and the high cost of operating a private practice creates this imperative to work hard in the rooms to cover costs.  There is poor separation of private and public consultative practice compared to Melbourne.  In other words, urologists are spending time in their rooms trying to cover their costs are probably too busy to think about academic pursuits.

What of university funded positions? Some surgical specialties such as vascular surgery, colorectal surgery, breast/endocrine surgery and upper gastrointestinal tract surgery will have paid academics in almost all of the teaching hospitals at the expense of subspecialties.  But the situation is no different between Sydney and Melbourne. 

Is anything else different?  The most striking difference is the manner by which public hospital urology units have been established.  There is a common thread amongst all of the key academic centres in Melbourne.  In each of these, the Heads of the Urology Departments were all appointed when relatively young in their careers and these positions tied in with academic appointments.  These urologists were able to carve out academically strong departments in their own style.  To name a few, we have Professors Damien Bolton, Mark Frydenberg and Anthony Costello.  They all built departments from an almost embarrassing levels of infrastructure and nothing more or less than what any department in Sydney would have had when they began their academic tenure.  They have now mentored a fossil layer to whom they can hand over the baton and those mentored, already hold major positions within international organisations and urological journals and are already well established international key opinion leaders.  Can we say the same about Sydney?  Sadly not and hence the comments from our Canadian friend. Within an established academic environment as has been created in Melbourne, it is substantially easier to maintain the academic throughput but if there is none to begin with, as is the case in just about every urological unit in Sydney, what hope is there.

To effect change in Sydney, future academic leaders need to be identified and offered positions of department leadership with associated university positions while they are young energetic and full of bright ideas.  They will make mistakes and will grow as a result of them.  What they do create will outweigh any risk associated with placing a relatively inexperienced leader into the helm.  These leaders need to be supported to grow their departments in their own style and with a long term vision in mind.  To move forward, either current department heads should make way for new leaders or as they retire, appropriate succession planning for a strong academic head should be in place.  Over the years I have seen numerous Sydney trained urologists who could have been great leaders that could have steered Sydney public hospital units to the same level of international recognition as those in Melbourne but have been lost to battlefields of private practice. Following their post fellowship training, they return to public hospital units with no existing academic infrastructure or capacity to develop such infrastructure.

As far as academic urology in Sydney is concerned, we punch way below our weight.  The Melbourne situation demonstrates precisely where we should be and precisely what is possible if there is a will to effect change.


(Footnote - some grammatical corrections have been made since first published. I really should proof read a little better)

Sunday, April 6, 2014

Tips For Junior Surgical Registrars by Dr Kesley Pedler

This is the first ever guest blog piece on "Surgical Opinion."  It is written by Dr Kesley Pedler who has just completed the Surgical Education & Training (SET) in Urology.  We are on the brink of seeing her enter urological practice and in this piece she shares tips on the day to day work as a surgical trainee.  I think you will all quickly gather that Dr Pedler is going to be one of those individuals who will create their own luck. - Henry Woo

_______________________________________________________________________


Tips for junior registrars (SET 1 to 3): things I wish I knew when I started my training

This week I completed my SET Urology training! It has been quite a journey and I have learnt a great deal from my many mentors over the last six years.  I have decided to share a few tips which I have figured out over the last few years which I have found helpful in performing my day to day job as a urology registrar. 

These tips will help you become an organised, competent, efficient and mature registrar which means your consultants will be more likely to increase your level of responsibility both inside and outside theatre which will allow you to learn more!

Be organised! ( especially for operating lists)

·       Know the cases beforehand:
o   This includes the indication for the procedure and results of relevant investigations .
o   This will help you understand the decision making process that has lead to your consultant bringing the patient to theatre.
o   Make sure you review the relevant imaging beforehand and display in the theatre (e.g. for a radical nephrectomy- make sure the CT is displayed demonstrating the tumour and also the vascular anatomy)

·       Know what major cases are coming up a few weeks in advance
o    Your consultants will expect you to know
o   This also gives you time to prepare for the case and read-up in advance. If you demonstrate understanding and knowledge of the operative steps, your consultant will feel a lot more comfortable letting you perform a significant part of the operation.
o   Befriend the administration staff in the bookings office in order to preview lists ahead of time.

·       Be punctual
o   Ensure you allow enough time to arrive on time (or even early) to theatres
o   This means scheduling enough time beforehand to complete ward rounds
o   Unless there has been an unforseen emergency elsewhere, avoid arriving at your theatre list after your consultant (and they will take note especially if this is a recurring occurrence).

Keep a notebook of details of operations
·       I have found it useful to keep a record of the particulars of certain procedures. This includes pre-op preparation, patient positioning, intra-operative details of each step including details such as particular sutures used and post operative management.
·       This can either be in the form of a notebook or keeping copies of select operation reports
·       This is invaluable since it will be a good reference to read before doing the particular case next time
o   Your consultant will be impressed you recall the details of the procedure and will be more likely to let you do more the next time.
o   You will often find that different consultants will perform the same procedure slightly differently and you will be expected to perform the procedure in their specific fashion.
·       This is also a useful resource in preparation for the operative viva in the fellowship examination.
·       It may also be useful when starting consultant practice- you can pick and choose which way you will perform a particular procedure according to what you have seen work well during your training.

Be organised outside the operating theatre
·       Keep a list of your inpatients close at hand
o   It is impossible to remember all details
o   I use this to record important information such as drain outputs, salient blood results and pending investigations.
o   I then refer to it when speaking to consultants about their patients (and jot down instructions and changes to the plan)

Think before calling your consultant
·       Have a definite purpose to your phone call
·       Think about how you will present your case before dialling.
·       Articulate your plan of management (even if you are not sure, suggest what you think is appropriate, it will help your learning even if you are incorrect)
·       Have a list of all your consultants patients plus any other issues you need to discuss so that all issues are dealt with in one phone call

Think beyond the acute hospital admission
·       This can take a little time to develop since as junior doctors we are only exposed to the acute hospital setting which is predominantly focused upon discharging patients
·       Think about what long term follow-up, investigations and future procedures are required. This will help you learn to manage the patient completely- a skill necessary in consultant practice and this will be assessed in the exam.

Look after yourself
·       Try to get enough sleep, eat and exercise when you can (although this is not always possible)
·       Have a proper holiday (i.e. going away and not thinking about study or work) at least once a year.

Remember that there is more to life than just urology!
·       Don’t neglect the significant people in your life (family, partners, friends). This is what is really important in life and it can be difficult to keep this a priority when your work and training often clash with other life events. 

·       The last thing you want is for the significant people in your life to feel of lesser importance than your work.


     (This piece was originally published in the USANZ Training Newsletter called "Bridges" in  February 2014. Dr Pedler has been kind enough to allow this piece to be reproduced here)


Sunday, March 9, 2014

Men with High Gleason Score Prostate Cancer should be given honest appraisals and expectations of outcomes from treatment

Men with a Gleason score 8-10 cancers have a significant chance of not being cured by radical prostatectomy.  Only in very exceptional circumstances would a man with a Gleason score 8-10 cancer be offered surgery if extent of disease scans (typically scans such as a bone scan and CT scan of the abdomen and pelvis) show evidence of spread to other organs.  

The vast majority of men with Gleason score 8-10 prostate cancer are offered surgery because there is no objective sign of cancer spread on scans and provided other factors such as age and concurrent medical problems are not likely to be an issue.  The big BUT is that if such scans fail to show signs of spread, it does not mean that spread has not occurred.  We know for a significant number (at least 30-50%) will have already had microscopic spread that is simply beyond the resolution of the scans to detect.  In other words, let’s say that some cancer cells from the prostate gland have managed to enter into blood vessels or lymphatic vessels and travel all the way to either the bones or lymph glands respectively. Remember that tiny deposits less than a millimetre is size would have no chance of being seen by a scan.  Before operating on such men, we need to be honest with them about this possibility.  They need to recognise that even if we are to successfully remove the prostate and have the prostate specimen margins free of cancer, it does not mean that they have necessarily been cured.  It is simply one of a number of hurdles that have been jumped over.

Having a Gleason score 8-10 prostate cancer is bad enought but if we look at men who have Gleason score 10 cancer in particular, we would regard these men as having a very high (not just high) risk of existing microscopic spread.  When these men undergo radical prostatectomy, a typical expectation is that less than 40% will be alive in 10 years without having signs of detectable spread of the cancer.  Even fewer will be alive with signs of cancer having returned as evidenced by their PSA blood test levels. In other words, most men with Gleason score 10 cancer will not be able to be cured.  This of course does not mean that these men should not be offered treatment with curative intent but it is an indication that appropriate counselling be offered and that men not be given false expectations about their prognosis.  It would be brave to suggest to such men that after surgery for a Gleason score 10 cancer, that they had ‘beaten it’ just because the surgical specimen showed that the excision margins did not have cancer at the edges (also known as positive surgical margins).  Another consideration is that these men who have arguable the worst prognosis, should be offered the opportunity to participate in clinical trials give them access to additional promising treatments that could offer them the best hope of overcoming these cancers. In my opinion, this is less likely to be offered in the setting of treatment by commercially driven surgeons.

There is more to treatment decision making processes than what the Gleason score is found to be on prostate biopsies. This blog piece attempts to show just one aspect of how we consider how we embark upon offering the best for our patients. 

The intention was not to make this blog piece sound like an argument against offering men with the most aggressive prostate cancers any treatment.  I regularly offer men with clinically localised 'high risk' prostate cancer treatment with curative intent.  In spite of our recognition that many will experience signs of failure to cure the disease, treatment offers these men their best chance.  Recent randomised control trial data shows that there is increasing evidence that treatment for this particular group of men makes a clinically relevant impact upon their survival.   

On a final note, I draw attention to a tweet from Dr David Samadi who is a 'celebrity' urologist who claims cure rates of 97% from prostate cancer surgery - he indicates that he has a patient who had just recently undergone surgery who had now ‘beaten the disease’ and is celebrating. You make up your own mind whether the patient has been given realist expectations on what the future holds for his cancer.  When the PSA starts rising, will Dr Samadi look after him now that the surgery is done, or simply refer him to another specialist (medical or radiation oncologist) to manage something that is no longer for him to look after? I do not know the answers to these questions but leave it in your mind to decide.


Sunday, February 16, 2014

First Data Published from a Twitter Based Journal Club

It is pleasing to report the ongoing success of the International Urology Journal Club on Twitter.  The first 12 months experience has culminated in the publication of a manuscript in the journal European Urology.  This is the highest impact journal in the field of urology at 10.476.   

Link to the article is at:-


The manuscript is expected to be indexed on Pubmed any day from now.

The 48-hour asynchronous format has worked well for time poor surgeons who find it difficult to commit to a designated on line meeting time.  The format has also enabled global involvement given that time zones are no longer an issue.  This is not to cast criticism at the fixed time journal clubs.  As a relatively small surgical specialty, global involvement is necessary to have sufficient participation to make it viable.  Larger specialty interest groups enable regional fixed time journal clubs to flourish.

Following on from our model is the commencement of a respiratory and sleep medicine journal club (#rsjc) and one from the general surgeons (#igsjc). We are eager to see that they succeed.


We will see more online journal clubs and hopefully more data to quantify participation and value as a CME learning tool.

Sunday, February 2, 2014

Be SMART about how you read the marketing. For prostate cancer, conditions apply.

I normally do not read inflight magazines from airlines as they find them quite boring. They are generally full of articles about travelling to exotic places or buying expensive products that only those who have so much money (that they do not know what to do with it) will have any interest.  This week, I was flying on the luxury carrier Emirates for the very first time and during the process of checking out all that they had to offer on my very long haul flight from Sydney to London via Dubai, I flicked through their inflight magazine. 

I was taken by surprise to see a very prominent advertisement by a urological surgeon offering his surgical services for the treatment of prostate cancer.  Given that I practice in this same subspecialized area of surgery, this naturally caught my attention.

Prior to seeing this advertisement, I had become aware of Dr David Samadi for all the wrong reasons. I had become aware of his name through overhearing discussions amongst US urologists over a number of years when attending the Annual Meeting of the American Urological Association.  I would frequently hear urologists discussing him with the gist of the discussion being summed up with the frequent rolling of the eyeballs or groan every time his name was mentioned.  Whilst urologists were careful not to verbally state anything negative about him, it was clear that they did not think favorably of him.  At the time and as an outsider, I really didn’t take that much notice as any gripes US colleagues had about him were not particularly relevant to me. 


So when I saw this advertisement in the Emirates inflight magazine, I immediately recognized his name and remember it being associated with groans and eyeball rolling.  As I read the advertisement, I now found myself rolling my eyes and groaning in disbelief.  It was almost like US urologists saying to a previously disinterested me, ‘told you so’.

Mobile phone captured image from the January 2014 Emirates inflight magazine
The statement that really got my attention was his claim of a “97% prostate cancer cure rate”.  When we talk about cure of cancer, we generally mean total and permanent eradication of the disease. Whilst one could argue through dictionary meanings that cure can mean recovery from disease or restoration of health, I think that the average person would interpret cure of cancer being total and permanent eradication of cancer.  My personal view is that prostate cancer doctor can come close to providing a 97% cure of prostate cancer and data shows that this is probably impossibility unless the subjects were all men with such low volume indolent disease that they did not need surgery in the first place.  Why is this an issue?  The statement can give cancer sufferers unrealistic expectations.  The statement is unquestionably a draw card to consider his services as it gives hope and promise of an exceptional chance of success but I am sure that. I did call him out on Twitter to clarify his claim of 97% cure rates and was not surprised that he chosen not to respond.


I did call him out on Twitter to clarify his claim of 97% cure rates and was not surprised that he had chosen not to respond.

The statement “96% of patients regain continence” is not defined.  Continence as far as I am concerned means a man who does not leak urine at all.  If we look at the prevalence of incontinence in ageing men, a 96% continence rate is higher than for men who have not undergone prostate cancer surgery.  It would be very easy to make a ridiculous suggestion that the surgery seems to give better urinary control rates than if you did not have surgery and one should therefore line up to have surgery with cancer being a mere technicality. – again I emphasise that this is a ridiculous suggestion but it does raise the question as what is meant by this claim.  What is meant my continence? Does it include the men who are wearing one pad per day or doesn’t wear a pad but drips urine everytime he has a cough or sneeze.  Undefined, the figure is very impressive and all those attracted by such figures should seek to clarify exactly what is meant be this.  The population of men in whom you operate can make a difference as well – older men are more likely to have incontinence than younger men as one example.

Same applies to erectile function recovery. I personally think that statement that “85% men regain sexual function” is very vague but nonetheless will be interpreted by most readers that it refers to erections.  My own overall figures do not come close to this.  However, if I were to narrow it down to my younger men in whom the cancer was considered to be well localized and they were candidates for nerve sparing (nerves that spare erectile function) surgery, then this might be a more realistic figure. 'Regain' implies recovery to where they were prior to surgery – that’s how I interpret it but I know that some may argue otherwise.  I have quite a number of men who have lost erections following prostate cancer surgery, particularly when I have had to sacrifice the erectile nerves in order to clear the cancer but they remain sexually active in that with their partners they achieve a pleasurable orgasm with a flaccid penis. I have men who are sexually active with the assistance of medications such as Viagra and Cialis or even with the use of medications that they inject into their penis in order to stimulate an erection (eg Caverject, trimix) but should that constitute ‘regain’ of sexual function?. 

For both continence and sexual function, definitions are everything and without them, I am concerned that presentation of such exceptional results will create unrealistic expectations.  I am sure that the man with locally advanced cancer will be appropriately counseled that he would not fit in the group with such good results but the advert would have done its job of pulling him in through the consultation door so that he can then told what he really can expect. Should there be a asterixed disclaimer as in every good advertising offer that 'conditions apply'.

The statement “When you’re the best in the world” also raises questions. What evidence does he have that he is a superior surgeon clinically and technically than anybody else in the world?  How does he benchmark this?  Is it fair to claim that just because you have had patients from 40 different countries that this must mean that you're are the best?  Is this international spread of patients have any relationship to international based marketing strategies?

I am currently registered as a medical practitioner with the Australian Health Practitioners Regulatory Authority.  AHPRA has strict advertising guidelines. There is also a code of conduct published by the Royal Australasian College of Surgeons (and endorsed by the Urological Society of Australia and New Zealand) that dictates my appropriate behavior as a surgeon.  If I were to have written such an advertisement, I would unquestionably be investigated by AHPRA and run risk of punitive actions and I would also stand a significant chance of being stripped of my surgical diploma from the RACS for breaches to our code of conduct. Dr Samadi is not required to adhere to Australian licencing regulations or code of conduct but in my opinion, there appears to be a lower bar for this behaviour in the United States. In Australia, any statements that have a likelihood of being misinterpreted as well as not being able to be substantiated are taken seriously and run a high risk of punitive sanctions and reputational loss.  Having previously been registered with the General Medical Council of the UK (when I worked there years ago), I can also say that their guidances on these matters are equally, if not more, restrictive.  It is important to state that these restrictions are not to make life harder for doctors to promote their practices, but to protect the public from misleading or unsubstantiated claims.

As a urological surgeon, I personally feel embarrassed to see such a colleague resort to advertisements in international inflight magazines to market their surgical practice. Maybe I'm just a bit old fashioned with my attitude to medical advertising. I was further embarrassed as a surgeon to see Dr Samadi refer to his twitter followers as fans. I hope that does not include his patients.